Top

Tip

Swipe om te navigeren naar een ander artikel

Gepubliceerd in:

23-05-2021

The effect of treatment and coping on the quality of life in breast cancer patients: a moderated mediation model

Auteurs: Lorena Gutiérrez-Hermoso, Lilian Velasco-Furlong, Sofía Sánchez-Román, Elisabeth Berzal-Pérez, Natasha Alcocer-Castillejos, Paulina Quiroz-Friedman

Gepubliceerd in: Quality of Life Research | Uitgave 1/2022

Abstract

Purpose

Breast cancer involves complicated emotional processes. One of the factors that impacts the psychological symptoms and decreases QoL is the side effects of treatment. The purpose of this study is to explore the effect of the main medical treatment (chemotherapy or hormone therapy) on the three domains of quality of life. For this, coping strategies were considered as psychological variables that mediate the relationship based on high or low alexithymia as a moderating variable.

Methods

This study had a cross-sectional design. The participant sample comprised 129 women with breast cancer in early stage (I to III) (63 receiving chemotherapy and 66 hormone therapy) and were evaluated from September 2015 to September 2019. Physical, emotional and social functioning were measured by the Quality of Life Questionnaire for cancer patients (EORTC-QLQ-C30), coping strategies were measured by Mental Adjustment to Cancer Questionnaire (MAC) and alexithymia was evaluated by the Alexithymia Toronto Scale (TAS-20).

Results

Treatment had a significant negative effect on physical domain in both patients receiving chemotherapy and hormone therapy. Moderated mediation analysis show that this relationship was significant when it was mediated by helplessness. Furthermore, this model is only significant when there are high levels of alexithymia. No significant effect direct was found on emotional and social functioning of quality of life.

Conclusions

Results confirmed that coping based on helplessness and stable emotional variables such as alexithymia can have an effect, mediator or moderator, respectively, in the decrease of the physical functionality of women with breast cancer. Our findings highlight the need to include psychological therapy to help patients alleviate their psychological state because it can affect their physical condition.

vorige artikel How patients being treated for non-small cell lung cancer value treatment benefit despite side effects

volgende artikel Beyond viral suppression: Quality of life among stable ART clients in a differentiated service delivery intervention in Tanzania

Alleen toegankelijk voor geautoriseerde gebruikers

American Cancer Society. (2019). Cancer statistics cancer. Retrieved from https://cancerstatisticscenter.cancer.org/?_ga=2.257816456.2018067078.1551266895-30426055.1530529872#!/cancer-site/Breast. Accessed 6 August, 2020

Legido-Quigley, H., Mateos-García, J. T., Regulez Campos, V., Gea-Sánchez, M., Muntaner, C., & McKee, M. (2020). The resilience of the Spanish health system against the COVID-19 pandemic. Lancet Public Health, 5, E251–E252. PubMedPubMedCentralCrossRef

Dantzer, R., Meagher, M. W., & Cleeland, C. S. (2012). Translational approaches to treatment-induced symptoms in cancer patients. Nature Reviews Clinical Oncology, 9(7), 414–426. https://doi.org/10.1038/nrclinonc.2012.88 PubMedPubMedCentralCrossRef

Bottomley, A. (2002). The cancer patient and quality of life. The Oncologist, 7, 120–125. PubMedCrossRef

Quatropani, M. C., Lenzo, V., & Filastro, A. (2017). Predictive factors of anxiety and depression symptoms in patients with breast cancer undergoing chemotherapy. An explorative study based on metacognitions. J Psychopath, 23(2), 67–73.

Ganz, P. A. (2006). Monitoring the physical health of cancer survivors: A survivorship-focused medical history. Journal of Clinical Oncology, 24(32), 5105–5111. PubMedCrossRef

Early Breast Cancer Trialists’ Collaborative Group (EBCTCG), Peto, R., Davies, C., Godwin, J., Gray, R., Pan, H. C., Clarke, M., Cutter, D., Darby, S., McGale, P., Taylor, C., Wang, Y. C., Bergh, J., Di Leo, A., Albain, K., Swain, S., & PiccartPritchard, M. K. (2012). Comparisons between different polychemotherapy regimens for early breast cancer: Meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. Lancet, 379(9814), 432–444. https://doi.org/10.1016/S0140-6736(11)61625-5 CrossRef

De Jong, N., Candel, M. J. J. M., Schouten, H. C., Abu-Saad, H. H., & Courtens, A. M. (2006). Course of the fatigue dimension activity level and the interference of fatigue with daily living activities for patients with breast cancer receiving adjuvant chemotherapy. Cancer Nursing, 29(5), E1–E13. PubMedCrossRef

Robinson, S., Kissane, D. W., Brooker, J., et al. (2015). A systematic review of the demoralization syndrome in individuals with progressive disease and cancer: A decade of research. Journal of Pain Symptom Management, 49(3), 595–610. https://doi.org/10.1016/j.painsymman.2014.07.008 PubMedCrossRef

10.

Lindner, O. C., Mayes, A., McCabe, M. G., & Talmi, D. (2017). Acute memory deficits in chemotherapy-treated adults. Memory, 25(10), 1327–1339. https://doi.org/10.1080/09658211.2017.1300667 PubMedCrossRef

11.

DiSipio, T., Rye, S., Newman, B., & y Hayes, S. . (2013). Incidence of unilateral arm lymphoedema after breast cancer: A systematic review and meta-analysis. The Lancet Oncology, 14(6), 500–515. PubMedCrossRef

12.

Darby, S. M. (2011). Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: Meta-analysis on individual patient data for 10,801 women in 17 randomised trials. Lancet, 378(9804), 1707–1716. https://doi.org/10.1016/S0140-6736(11)61629-2 PubMedCrossRef

13.

Reidunsdatter, R. J., Rannestad, T., Frengen, J., Frykholm, G., & Lundgren, S. (2010). Early effects of contemporary breast radiation on health-related quality of life: Predictors of radiotherapy related fatigue. Acta Oncologica, 50, 1175–1182. https://doi.org/10.3109/0284186.X.2011.604345c CrossRef

14.

Bright, E. E., & Stanton, A. L. (2018). Prospective investigation of social support, coping and depressive symptoms: A model of adherence to endocrine therapy among women with breast cancer. Journal of Consulting and Clinical Psychology, 86(3), 242–253. https://doi.org/10.1037/ccp0000272 PubMedCrossRef

15.

Moon, Z., Hunter, M. S., Moss-Morris, R., & Hughes, L. D. (2017). Factors related to the experience of menopausal symptoms in women prescribed tamoxifen. Journal of Psychosomatic Obstetrics and Gynaecology, 38(3), 226–235. https://doi.org/10.2080/0167482X.2016.1216963 PubMedCrossRef

16.

Boehm, D. U., Lebrecht, A., Eckhardt, T., Albrich, S., Schmidt, M., Siggelkow, W., Kanderhardt, E., & Koelbl, H. (2009). Quality of life and adjuvant tamoxifen treatment in breast cancer patients. Europ. J. Cancer Care, 18, 500–506. https://doi.org/10.1111/j.1365-2354.2008.01015.x CrossRef

17.

Li, H., Sereika, S. M., Marsland, A. L., Conley, Y. P., & Bender, C. M. (2019). Impact of chemotherapy on symptoms and symptom cluster in postmenopausal women with breast cancer prior to aromatase inhibitor therapy. Journal of Clinical Nursing, 28(23–24), 4560–4571. PubMedCrossRef

18.

Watson, M., & Homewood, J. (2008). Mental adjustment to cancer scale: Psychometric properties in a large cancer cohort. Psycho Oncology, 17(11), 1146–1151. PubMedCrossRef

19.

Bronner, M. B., Nguyen, M. H., Smets, E. M. A., van de Ven, A., & van Weert, J. (2018). Anxiety during cancer diagnosis: Examining the influence of monitoring coping style and treatment plan. Psycho Oncology, 27(2), 661–667. https://doi.org/10.1002/pon.4560 PubMedCrossRef

20.

Paek, M. S., Ip, E. H., Levine, E., & Avis, N. E. (2016). Longitudinal reciprocal relationships between quality of life and coping strategies among women with breast cancer. Annals of Behavioral Medicine, 50(5), 775–783. https://doi.org/10.1007/s12160-016-9803-y PubMedCrossRef

21.

Andreu, Y., Galdón, M. J., Durá, E., Martínez, P., Pérez, S., & Murgui, S. (2017). A longitudinal study of psychosocial distress in breast cancer: Prevalence and risk factors. Psychol & Health, 27(1), 72–87. https://doi.org/10.1080/08870446.2010.542814 CrossRef

22.

Religioni, U., Czerw, A., & Deptala, A. (2018). Patient mental adjustment to selected types of cancer. Psychiat Polska, 52(1), 129–141. CrossRef

23.

Stanton, A. L., Petrie, K. J., & Partridge, A. H. (2014). Contributors to non-adherence and non-persistence with endocrine therapy in breast cancer survivors recruited from an online research registry. Breast Cancer Research and Treatment, 145(2), 525–534. https://doi.org/10.1007/s10549-014-2961-3 PubMedCrossRef

24.

Zhang, J., Zhou, Y., Feng, Z., Xu, Y., & Zeng, G. (2018). Longitudinal trends in anxiety, depression, and quality of life during different intermittent periods of adjuvant breast cancer chemotherapy. Cancer Nursing, 41(1), 62–68. https://doi.org/10.1097/NCC.0000000000000451 PubMedCrossRef

25.

Luutonen, S., Sintonen, H., Stormi, T., & Salminen, E. (2014). Health-related quality of life during adjuvant radiotherapy in breast cancer. Quality of Life Research, 23(4), 1363–1369. https://doi.org/10.1007/s11136-013-0554-y PubMedCrossRef

26.

Ho, R. T. H., Kwan, T. T. C., Cheung, I. K. M., Chan, C. K. P., Lo, P. H. Y., Yip, P. S. F., Luk, M., & Chan, C. L. W. (2015). Association of fatigue with perceived stress in Chinese women with early stage breast cancer awaiting adjuvant radiotherapy. Stress and Health, 31(3), 214–221. PubMedCrossRef

27.

De Vries, M., Forni, V., Voellinger, R., & Stiefel, F. (2012). Alexithymia in cancer patients: Review of the literature. Psychoth Psychosom, 81(2), 79–86. https://doi.org/10.1159/000330888 CrossRef

28.

Marrazzo, G., Sideli, L., Rizzo, R., Marinaro, A. M., Mulè, A., Marrazzo, A., La Cascia, C., & La Barbera, D. (2016). Quality of life, alexithymia, and defence mechanisms in patients affected by breast cancer across different stages of illness. Journal of Psychopathology, 22(2), 141–148.

29.

Luminet, O., Rokbani, L., Ogez, D., & Jadoulle, V. (2007). An evaluation of the absolute and relative stability of alexithymia in women with breast cancer. Journal of Psychosomatic Research, 62(6), 641–648. PubMedCrossRef

30.

Baudic, S., Jayr, C., Albi-Feldzer, A., Fermanian, J., Masselin-Dubois, A., & Attal, N. (2016). Effect of alexithymia and emotional repression on postsurgical pain in women with breast cancer: A prospective longitudinal 12-month study. The Journal of Pain, 17(1), 90–100. https://doi.org/10.1016/j.pain.2015.10.001 PubMedCrossRef

31.

Gritti, P., Lombardi, S., Nobile, B., et al. (2010). Alexithymia and cancer related fatigue: A controlled cross-sectional study. Tumori, 96(1), 131–137. https://doi.org/10.1177/030089161009600121 PubMedCrossRef

32.

Boinon, D., Sultan, S., Charles, C., Rosberger, Z., Delaloge, S., & y Dauchy, S. . (2012). How social sharing and social support explain distress in breast cancer after surgery: The role of alexithymia. Journal of Psychosocial Oncology, 30(5), 573–592. PubMedCrossRef

33.

Zebrack, B., Burg, M. A., & Vaitones, V. (2012). Distress screening: an opportunity for enhancing quality cancer care and promoting the oncology social work profession. Journal of Psychosocial Oncology, 30(6), 615–624. https://doi.org/10.1080/07347332.2012.72148 PubMedCrossRef

34.

Arrarás Urdaniz, J. I., Villafranca Iturre, E., Arias de la Vega, F., Domínguez Domínguez, M. A., Lainez Milagro, N., Manterola Burgaleta, A., et al. (2008). The EORTC quality of life questionnaire QLQ-C30 (Version 3.0). Validation study for spanish prostate cancer patients. Archivos Espanoles de Urologia, 61(8), 949–957. https://doi.org/10.4321/s0004-0614200800080017 PubMedCrossRef

35.

Ferrero, J., Barreto, M. P., & Toledo, M. (1994). Mental adjustment to cancer and quality of life in breast cancer patients: An exploratory study. Psycho Oncology, 3(3), 223–232. https://doi.org/10.1002/pon.2960030309 CrossRef

36.

Martínez-Sánchez, F. (1996). Adaptación española de la escala de alexitimia de Toronto (TAS-20). Clínica y Salud, 7(1), 19–32.

37.

Hayes, A. F. (2013). Introduction to mediation, moderation, and conditional process analysis: A regression-based approach. New York: Guilford Press.

38.

Baron, R., & Kenny, D. (1986). The moderator-mediator variable distinction in social psychological research: Conceptual, strategic and statistical considerations. Journal of Personality and Social Psychology, 51(6), 1173–11782. https://doi.org/10.1037//0022-3514.51.6.1173 PubMedCrossRef

39.

American Joint Committee on Cancer (AJCC). (2017). Cancer Staging Manual, 8th edition. In: Amin M. B., Edge, S., Greene, F., Byrd, D. R., Brookland, R. K., Washington, M. K., et al. (Eds.). New York: Springer.

40.

GLOBOCAN. (2018). Global Cancer Data. Retrieved from https://www.uicc.org/news/global-cancer-data-globocan-2018.

41.

Hooning, M. J., Aleman, B. M. P., Hauptmann, M., Baaijens, M. H. A., Klijn, J. G. M., & Noyon, R. (2016). Roles of radiotherapy and chemotherapy in the development of contralateral breast cancer. Journal of Clinical Oncology, 26(34), 5561–5568. https://doi.org/10.1200/JCO.2007.16.0192y CrossRef

42.

Bayram, Z., Durna, Z., & Akin, S. (2014). Quality of life during chemotherapy and satisfaction with nursing care in Turkish breast cancer patients. European journal of cancer care, 23(5), 675–684. https://doi.org/10.1111/ecc.12185 PubMedCrossRef

43.

Ganz, P. A., Desmond, K. A., Leedham, B., Rowland, J. H., Meyerowitz, B. E., & Belin, T. R. (2002). Quality of life in long-term, disease-free survivors of breast cancer: A follow-up study. Journal of the National Cancer Institute, 94, 39–49. https://doi.org/10.1093/jnci/94.1.39 PubMedCrossRef

44.

Burstein, H. J., Prestrud, A. A., Seidenfeld, J., Anderson, H., Buchholz, T. A., Davidson, N. E., et al. (2010). American Society of Clinical Oncology clinical practice guideline: Update on adjuvant endocrine therapy for women with hormone receptor–positive breast cancer. Journal of Clinical Oncology, 28, 3784–3796. PubMedPubMedCentralCrossRef

45.

Cella, D., & Fallowfield, L. (2008). Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy. Breast Cancer Res and Treatment, 107, 167–180. CrossRef

46.

Villani, D., Cognetta, C., Toniolo, D., Scanzi, F., & Riva, G. (2017). An e-health protocol to help elderly breast cancer patients to cope with chemotherapy: Preliminary results. Annual Review of Cyber Therapy and Telemedicine, 15, 27–32.

47.

Bellur, Z., Aydin, A., & Alpay, E. H. (2018). Mediating role of coping styles in personal, environmental and event related factors and posttraumatic growth relationships in women with breast cancer. The Journal of Clinical Psychiatry, 21(1), 38–51. https://doi.org/10.5505/kpd.2018.65365 CrossRef

48.

Donovan-Kicken, E., & Caughlin, J. P. (2011). Breast cancer patients’ topic avoidance and psychological distress: The mediating role of coping. Journal of Health Psychology, 16, 596–606. https://doi.org/10.1177/1359105310383605 PubMedCrossRef

49.

Munro, H., Scott, S. E., King, A., & Grunfeld, E. A. (2014). Patterns and predictors of disclosure of a diagnosis of cancer. Psycho-Oncology. https://doi.org/10.1002/pon.3679 PubMedCrossRef

50.

Folkman, S. (2013). Stress: Appraisal and coping. In D. Marc (Ed.), Gellman Encyclopedia of behavioral medicine (pp. 1913–1915). New York: Springer. CrossRef

51.

Smyth, J. M., & Arigo, D. (2009). Recent evidence supports emotion-regulation interventions for improving health in at-risk and clinical populations. Current opinion in Psychiatry, 22(2), 205–210. https://doi.org/10.1097/YCO.0b013e3283252d6d19553877 PubMedCrossRef

52.

Butow, P. N., Hiller, J. E., Price, M. A., Thackway, S. V., Kricker, A., & Tennant, C. C. (2000). Epidemiological evidence for a relationship between life events, coping style and personality factors in the development of breast cancer. Journal of Psychosomatic Research, 49(3), 169–181. PubMedCrossRef

53.

Gutiérrez Hermoso, L., Velasco Furlong, L., Sánchez-Román, S., & Salas Costumero, L. (2020). The importance of alexithymia in post-surgery. Differences on body image and psychological adjustment in breast cancer patients. Frontiers in psychology, 11, 604004. https://doi.org/10.3389/fpsyg.2020.604004 PubMedPubMedCentralCrossRef

54.

Bloom, J. R., Stewart, S. L., Johnston, M., Banks, P., & Fobair, P. (2001). Sources of support and the physical and mental well-being of young women with breast cancer. Social science & medicine, 53(11), 1513–1524. https://doi.org/10.1016/s0277-9536(00)00440-8 CrossRef

55.

Kunal, C. K., & Lynn, N. H. (2015). Adjuvant endocrine therapy in premenopausal women with breast cancer. Clinical Advances in Hematology & Oncology, 13(10), 663–672.

56.

Rattcliff, C. G., Lam, C. Y., Arun, B., Valero, V., & Cohen, L. (2014). Ecological momentary assessment of sleep, symptoms, and mood during chemotherapy for breast cancer. Psycho-Oncology, 23(11), 1220–1228. https://doi.org/10.1002/pon.3525 CrossRef

57.

Velasco, L., Gutiérrez Hermoso, L., Alcocer Castillejos, N., Quiroz Friedman, P., Peñacoba, C., Catalá, P., & Sánchez-Román, S. (2020). Association between quality of life and positive coping strategies in breast cancer patients. Women & health, 60(9), 1063–1069. https://doi.org/10.1080/03630242.2020.1802398 CrossRef

58.

Tedeschi, R. G., & Calhoun, L. G. (1998). Posttraumatic growth: Conceptual issues. In L. G. Calhoun & R. G. Tedeschi (Eds.), Positive changes in the aftermath of crisis (pp. 1–22). Mahwah: Lawrence Erlbaum Associates.

Titel: The effect of treatment and coping on the quality of life in breast cancer patients: a moderated mediation model
Auteurs: Lorena Gutiérrez-Hermoso
Lilian Velasco-Furlong
Sofía Sánchez-Román
Elisabeth Berzal-Pérez
Natasha Alcocer-Castillejos
Paulina Quiroz-Friedman
Publicatiedatum: 23-05-2021
Uitgeverij: Springer International Publishing
Gepubliceerd in: Quality of Life Research / Uitgave 1/2022
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-021-02885-3

Mijn bibliotheek

Shop

Tips voor Mijn BSL

Bohn Stafleu van Loghum

Tip

Swipe om te navigeren naar een ander artikel

The effect of treatment and coping on the quality of life in breast cancer patients: a moderated mediation model

Abstract

Purpose

Methods

Results

Conclusions

Mijn bibliotheek

Shop

Tips voor Mijn BSL

Bohn Stafleu van Loghum

Tip

Swipe om te navigeren naar een ander artikel

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Purpose

Methods

Results

Conclusions

Log in om toegang te krijgen

Andere artikelen Uitgave 1/2022

Non-parametric measurement for patient-reported outcomes

Psychometric properties of the PROMIS-57 questionnaire, Norwegian version

Assessing forgetfulness and polypharmacy and their impact on health-related quality of life among patients with hypertension and dyslipidemia in Greece during the COVID-19 pandemic

The influence of psychosocial factors on patient-reported outcome measures in rotator cuff tears pre- and post-surgery: a systematic review

Correction to: Patients’ and parents’ perspective on the implementation of Patient Reported Outcome Measures in pediatric clinical practice using the KLIK PROM portal

Advances in nonparametric item response theory for scale construction in quality-of-life research